Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; ADAM; a disintegrin and metalloproteinase; AKT; protein kinase B; APAF 1; apoptotic protease activating factor 1; APC; adenomatous polyposis coli; ATG; autophagy protein; BAK; Bcl 2 homologous antagonist/killer; BAX; Bcl-2 associated -X protein; Bcl-2; B-
مقالات ISI گیرنده عامل فاکتور رشد هپاتوسیت (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; mAb; monoclonal antibody; BPD; benzoporphyrin derivative; PDT; photodynamic therapy; nanoPAL; nanophotoactivatable liposomes; PDAC; pancreatic ductal adenocarcinoma; VEGF; vascular endothelial growth factor; MAPK; mitogen activated protein kinases; HIF; h
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Afatinib (PubMed CID: 10184653); Crizotinib (PubMed CID: 11626560); Erlotinib (PubMed CID: 176870); Gefitinib (PubMed CID: 123631); Imatinib (PubMed CID: 5291); Nilotinib (PubMed CID: 644241); Sorafinib (PubMed CID: 216239); Sunitinib (PubMed CID: 5329102
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Receptor targeting; Hepatocyte growth factor receptor; Transferrin receptor; Shear flow; Cellular adhesion; Quantification;
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Antibodies; Immunoconjugates; Immunotoxins; Ab; antibody; Ag; antigen; ADCC; antibody-dependent cell mediated cytotoxicity; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; AKT; protein kinase B; APC; antigen-presenting cell; Apo2L/TRAIL; t
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Glioblastoma; Treatment; Review; Pharmacology; Targeted therapy; Stem cell; AKT; protein kinase B; BBB; blood-brain barrier; BCNU; carmustin; CCNU; lomustin; c-MET; hepatocyte growth factor receptor; EGF(R); epidermal growth factor (receptor); EGFRvIII; e
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; 2 DE; 2-dimensional electrophoresis; ABPP; activity-based protein profiling; BFGF; basic fibroblast growth factor; CML; chronic myeloid leukemia; CRC; colorectal cancer; DIGE; differential in gel electrophoresis; EGF(R); epidermal growth factor (receptor)
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Superresolution/Localization microscopy; nanoscopy; Influenza viruses; Hepatocyte growth factor receptor; Single molecules; SPDM; SMLM; SALM;
The role of the ShcD and RET interaction in neuroblastoma survival and migration
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Akt,; Protein kinase B;; ALK,; Anaplastic Lymphoma Kinase; CMV,; Cytomegalovirus; DMEM,; Dulbecoo Modified Eagle's Medium;; DNA,; Deoxyribonucleic Acid; ECL,; Enhanced Chemiluminescence;; EGF,; Epidermal Growth Factor;; EGFR,; Epidermal Growth Factor Rece
Hepatic cell sheets engineered from human mesenchymal stem cells with a single small molecule compound IC-2 ameliorate acute liver injury in mice
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Hepatic cell sheets; Mesenchymal stem cells; Liver regeneration; Wnt/β-catenin signal inhibitor; Acute liver failure; BM-MSCs; bone marrow-derived mesenchymal stem cells; NF-κB; nuclear factor-kappa B; IL-6; interleukin-6; STAT-3; Signal Tranducer and A
Scaffold hopping identifies 6,8-disubstituted purines as novel anaplastic lymphoma kinase inhibitors
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; ALK; anaplastic lymphoma kinase; cMet; hepatocyte growth factor receptor; DIPEA; N,N-Diisopropylethylamine; DMF; N,N-Dimethylformamide; EML4; echinoderm microtubule-associated protein-like 4; FDA; food and drug administration; gk; gatekeeper; μW; micro w
Prognostic Factors in Skull Base Chordoma: A Systematic Literature Review and Meta-Analysis
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Meta-analysis; Prognosis; Prognostic factors; Skull base chordoma; Survival; CI; Confidence interval; c-Met; Hepatocyte growth factor receptor; EGFR; Epidermal growth factor receptor; HR; Hazard ratio; hTERT; Human telomerase reverse transcriptase; IR; In
Antibody-drug conjugates (ADCs): Potent biopharmaceuticals to target solid and hematological cancers- an overview
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Antibody-drug conjugates; Monoclonal antibodies; Anticancer; Drug resistance; Solid tumors; Hematological tumors; ADC; Antibody-Drug Conjugate; ALCL; Anaplastic Large Cell Lymphoma; ALL; Acute Lymphoblastic Leukemia; AML; Acute Myeloid Leukemia; BCMA; B C
Co-targeting c-Met and DNA double-strand breaks (DSBs): Therapeutic strategies in BRCA-mutated gastric carcinomas
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Gastric cancer; Hepatocyte growth factor receptor; c-MET; BRCA proteins; HR;
Phosphatidylethanolamine binding protein 4 (PEBP4) is a secreted protein and has multiple functions
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Act; protein kinase B; DMEM; Dulbecco's modified Eagle's medium; EGF; epidermal growth factor; ERK; extracellular signal regulated kinase; FBS; fetal bovine serum; GFP; green fluorescent protein; Her2; human epidermal growth factor receptor 2; HMGB1; high
Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Biomarker; Fluorescent in situ hybridization; Hepatocyte growth factor receptor; Immunohistochemistry; Prognosis;
Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Cancer targeted therapy; Met; Antibody; Fab; Half-life; Protein engineering; HGF; hepatocyte growth factor; HGFR; hepatocyte growth factor receptor; EGFR; epidermal growth factor receptor; mAb; monoclonal antibody; MvDN30; monovalent chimerized DN30 Fab;
Detection of Crizotinib-Sensitive Lung Adenocarcinomas With MET, ALK, and ROS1 Genomic Alterations via Comprehensive Genomic Profiling
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Anaplastic lymphoma kinase; C-ros oncogene 1; Hepatocyte growth factor receptor; Mutation; Next-generation sequencing;
Enhanced expression and phosphorylation of the MET oncoprotein by glioma-specific PTPRZ1-MET fusions
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; MET; hepatocyte growth factor receptor; PTPRZ1; receptor-type tyrosine-protein phosphatase zeta; ZM; PTPRZ1-MET fusion; HGF; hepatocyte growth factor; NGS; next generation sequencing; RTKs; receptor tyrosine kinases; GBM; glioblastoma multiform; FPKM; f
Rapid modification of the bone microenvironment following short-term treatment with Cabozantinib in vivo
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; CBZ; Cabozantinib; GFP Ob+; green fluorescent protein expressing cells of the osteoblastic lineage; CTRL; control; PBS; phosphate buffered saline; TRAP; tartrate resistant alkaline phosphatase; PINP; procollagen type 1 N-terminal propeptide; MET; hepatocy
Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; OS; osteosarcoma; miR or miRNA; microRNA; ncRNA; noncoding RNA; miR-34a; microRNA-34a; pre-miR-34a or mir-34a; pre-microRNA-34a; tRNA/mir-34a; transfer RNA fusion pre-miR-34a; CDK6; cyclin-dependent kinase 6; c-MET; hepatocyte growth factor receptor; SIRT
Pharmacology of novel small-molecule tubulin inhibitors in glioblastoma cells with enhanced EGFR signalling
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Bak; Bcl-2 antagonist/killer-1; Bax; Bcl-2-associated X protein; Bcl-2; B-cell lymphoma 2; Bcl-XL; B-cell lymphoma-extra large; cMet; hepatocyte growth factor receptor; cmpd; compound; EGFR; epidermal growth factor receptor; MAPK; mitogen-activated protei
Ginsenoside-Rg1 induces angiogenesis by the inverse regulation of MET tyrosine kinase receptor expression through miR-23a
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Ginsenoside-Rg1; MET; Hepatocyte growth factor receptor; Angiogenesis; miR-23a; microRNA;
Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: Focus on the role and impact of proteoglycans
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; ER; estrogen receptor; PgR; progesterone receptor; HER2/erbB2; human epidermal growth factor receptor-2; E2; estradiol; RTK; receptor tyrosine kinase; IGF-IR; insulin-like growth factor I receptor; EGFR; epidermal growth factor receptor; MAPK; mitogen act
The Importance of Molecular Profiling in Predicting Response to Epidermal Growth Factor Receptor Family Inhibitors in Non–Small-Cell Lung Cancer: Focus on Clinical Trial Results
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Epidermal growth factor receptor tyrosine kinase inhibitor; Gene amplification; Hepatocyte growth factor receptor; Kirsten rat sarcoma viral oncogene homolog; Phosphoinositide-3-kinase
Rationale and Design of MARQUEE: A Phase III, Randomized, Double-Blind Study of Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib in Previously Treated Patients With Locally Advanced or Metastatic, Nonsquamous, Non–Small-Cell Lung Cancer
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Epidermal growth factor receptor; Hepatocyte growth factor receptor; MET; Tyrosine kinase inhibitors
An adjacent arginine, and the phosphorylated tyrosine in the c-Met receptor target sequence, dictates the orientation of c-Cbl binding
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; TKB; tyrosine kinase binding; SH2; Src homology 2; SPR; surface plasmon resonance; EGFR; epidermal growth factor receptor; Met; hepatocyte growth factor receptor; Cbl; casitas B-lineage lymphoma; c-Casitas B-lineage lymphoma tyrosine kinase binding domain
Further evidence for the role of MET in autism susceptibility
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Association study; Autism spectrum disorder; Candidate gene; Hepatocyte growth factor receptor; Neurodevelopment; Single nucleotide polymorphism
Preferential binding of anti-cancer drug adriamycin to the Sp1 binding site in c-met promoter region: A spectroscopic and molecular modeling study
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Adriamycin; c-met; DNA–drug interaction; Hepatocyte growth factor receptor; Cancer
Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase–2 and –7 and E-cadherin
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; Hepatocyte growth factor receptor; Matrix metalloproteinases; E-cadherin; Prognosis; Bladder cancer
Co-overexpression of Met and Hepatocyte Growth Factor Promotes Systemic Metastasis in NCI-H460 Non-Small Cell Lung Carcinoma Cells
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; HGF; hepatocyte growth factor; GFP; green fluorescent protein; Met; hepatocyte growth factor receptor; MMP-2; matrix metalloproteinase-2; MMP-9; matrix metalloproteinase-9; NSCLC; non-small cell lung cancer; SCID mice; severe combine immunodeficient mice;
C-Met antisense oligodeoxynucleotide inhibits growth of glioma cells
Keywords: گیرنده عامل فاکتور رشد هپاتوسیت; HGF; hepatocyte growth factor; c-Met; hepatocyte growth factor receptor; ASODN; antisense oligonucleotide; ODNs; oligodexynucleotides; NSODN; nonsense oligonucleotide; FCM; flow cytometry; MTT; methyl thiazole tetrazolium; FAM; caroboxyfluorescein-5-succi